본문으로 건너뛰기
← 뒤로

Letter to the Editor "Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor-positive, HER2-positive breast cancer".

Breast (Edinburgh, Scotland) 2026 Vol.86() p. 104716

Verma A, Hoysal DR, Deshpande A, Badwe RA

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Verma A, Hoysal DR, et al. (2026). Letter to the Editor "Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor-positive, HER2-positive breast cancer".. Breast (Edinburgh, Scotland), 86, 104716. https://doi.org/10.1016/j.breast.2026.104716
MLA Verma A, et al.. "Letter to the Editor "Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor-positive, HER2-positive breast cancer".." Breast (Edinburgh, Scotland), vol. 86, 2026, pp. 104716.
PMID 41644336

같은 제1저자의 인용 많은 논문 (4)